·
8 MIN READ

Feb. 18, 2022: National Advocacy Update

CMS urged to allow more time to review draft cost measures and more in the latest National Advocacy Update.

Advocacy Update
·
3 MIN READ

Feb. 18, 2022: State Advocacy Update

New toolkit highlights effective policies in combating drug overdoses and more in the latest State Advocacy Update.

Advocacy Update
·
2 MIN READ

AMA urges Administration to remove naloxone from behind the counter

Removing the prescription status of naloxone as an essential step to save lives from opioid-related overdose, helps to make naloxone available to patients.

Press Releases
·
4 MIN READ

Top news stories from AMA Morning Rounds®: Week of Feb. 7, 2022

In the news: New opioid prescribing guidelines, mask effectiveness against COVID-19, nonopioid pain management and more.

Publications & Newsletters
·
2 MIN READ

AMA welcomes draft CDC changes in opioid guidance

The AMA applauds the CDC for acknowledging the original guideline missed the mark.

Press Releases
·
3 MIN READ

AMA, Manatt Health unveil toolkit to combat drug overdoses

The AMA and Manatt Health release a toolkit to guide states on removing barriers to evidence-based patient care.

Press Releases
Patient and health care professional in conversation
·
4 MIN READ

Insurer accountability on mental health parity is long overdue

Report finds “egregious violations” of federal law, worsening nation’s mental health and drug-overdose crises. Learn more with the AMA.

Access to Care
·
4 MIN READ

Top news stories from AMA Morning Rounds®: Week of Jan. 31, 2022

In the news: COVID vaccination rates in children, surging opioid-related overdoses, FDA approval for Moderna vaccine and more.

Publications & Newsletters
·
2 MIN READ

Feb. 4, 2022: Advocacy Update spotlight on insurers' parity failures

AMA asks Congress to hold insurers accountable for nearly 15 years of parity failures and more in the latest Advocacy Update issue spotlight.

Advocacy Update